Advertisement
UK markets closed

  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     

  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     

  • CRUDE OIL

    79.13
    +0.13 (+0.16%)
     

  • GOLD FUTURES

    2,330.20
    +27.30 (+1.19%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • Bitcoin GBP

    46,170.21
    -1,826.42 (-3.81%)
     

  • CMC Crypto 200

    1,202.07
    -136.99 (-10.23%)
     

  • NASDAQ Composite

    15,605.48
    -52.34 (-0.33%)
     

  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     
Money:

Family finances

Who is the breadwinner in your family and does it matter?

BUZZ-AstraZeneca: dives off 1-yr highs after update

Reuters - UK Focus

** AstraZeneca (NYSE: AZN - news) top of the FTSE 100 fallers' list as some analysts query the sustainability of its EPS beat

** They flag that earnings were enhanced by the partial sell-off of a number of drugs

** Stock called up 1-2 pct by brokers in the pre-market; posts core EPS $1.08 (down 7 pct), above consensus $1.07, but shares dived off 1-yr highs hit recently & drop nearly 3 pct

** Deutsche Bank (Xetra: 514000 - news) reckons further question marks will be raised over the quality of earnings from the base business, though expects consensus EPS forecasts & pipeline-based investment case to be unchanged; repeats "hold" rating (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)